(2S,5S,8S,11S,17S)-17-((4R,10S,13S,16S,19S,22S,28S,31S,34S,37S,40S,43S,49S,52R)-52-((2S,5S,8S,11S,14S,17S,20S,23S,26S)-11-((1H-imidazol-4-yl)methyl)-26,28-diamino-20-(4-aminobutyl)-2,5,8,23-tetrakis(hydroxymethyl)-14-methyl-17-(2-(methylthio)ethyl)-4,7,10,13,16,19,22,25,28-nonaoxo-3,6,9,12,15,18,21,24-octaazaoctacosanamido)-43-(3-amino-3-oxopropyl)-40-(4-aminobutyl)-49-benzyl-28,37-di((S)-sec-butyl)-34-(carboxymethyl)-13,31-bis(3-guanidinopropyl)-16-(hydroxymethyl)-10-isobutyl-19-isopropyl-22-methyl-6,9,12,15,18,21,24,27,30,33,36,39,42,45,48,51-hexadecaoxo-1,2-dithia-5,8,11,14,17,20,23,26,29,32,35,38,41,44,47,50-hexadecaazacyclotripentacontane-4-carboxamido)-2-benzyl-8-(3-guanidinopropyl)-5,11-diisobutyl-4,7,10,13,16-pentaoxo-3,6,9,12,15-pentaazanonadecanedioic acid

Catalog No. :
ACFXCD755
CAS No. :
133448-20-1
Molecular Formula :
C146H239N47O44S3
Molecular Weight :
3453.00

IUPAC Name:(2S,5S,8S,11S,17S)-17-((4R,10S,13S,16S,19S,22S,28S,31S,34S,37S,40S,43S,49S,52R)-52-((2S,5S,8S,11S,14S,17S,20S,23S,26S)-11-((1H-imidazol-4-yl)methyl)-26,28-diamino-20-(4-aminobutyl)-2,5,8,23-tetrakis(hydroxymethyl)-14-methyl-17-(2-(methylthio)ethyl)-4,7,10,13,16,19,22,25,28-nonaoxo-3,6,9,12,15,18,21,24-octaazaoctacosanamido)-43-(3-amino-3-oxopropyl)-40-(4-aminobutyl)-49-benzyl-28,37-di((S)-sec-butyl)-34-(carboxymethyl)-13,31-bis(3-guanidinopropyl)-16-(hydroxymethyl)-10-isobutyl-19-isopropyl-22-methyl-6,9,12,15,18,21,24,27,30,33,36,39,42,45,48,51-hexadecaoxo-1,2-dithia-5,8,11,14,17,20,23,26,29,32,35,38,41,44,47,50-hexadecaazacyclotripentacontane-4-carboxamido)-2-benzyl-8-(3-guanidinopropyl)-5,11-diisobutyl-4,7,10,13,16-pentaoxo-3,6,9,12,15-pentaazanonadecanedioic acid

(2S,5S,8S,11S,17S)-17-((4R,10S,13S,16S,19S,22S,28S,31S,34S,37S,40S,43S,49S,52R)-52-((2S,5S,8S,11S,14S,17S,20S,23S,26S)-11-((1H-imidazol-4-yl)methyl)-26,28-diamino-20-(4-aminobutyl)-2,5,8,23-tetrakis(hydroxymethyl)-14-methyl-17-(2-(methylthio)ethyl)-4,7,10,13,16,19,22,25,28-nonaoxo-3,6,9,12,15,18,21,24-octaazaoctacosanamido)-43-(3-amino-3-oxopropyl)-40-(4-aminobutyl)-49-benzyl-28,37-di((S)-sec-butyl)-34-(carboxymethyl)-13,31-bis(3-guanidinopropyl)-16-(hydroxymethyl)-10-isobutyl-19-isopropyl-22-methyl-6,9,12,15,18,21,24,27,30,33,36,39,42,45,48,51-hexadecaoxo-1,2-dithia-5,8,11,14,17,20,23,26,29,32,35,38,41,44,47,50-hexadecaazacyclotripentacontane-4-carboxamido)-2-benzyl-8-(3-guanidinopropyl)-5,11-diisobutyl-4,7,10,13,16-pentaoxo-3,6,9,12,15-pentaazanonadecanedioic acid structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(2S,5S,8S,11S,17S)-17-((4R,10S,13S,16S,19S,22S,28S,31S,34S,37S,40S,43S,49S,52R)-52-((2S,5S,8S,11S,14S,17S,20S,23S,26S)-11-((1H-imidazol-4-yl)methyl)-26,28-diamino-20-(4-aminobutyl)-2,5,8,23-tetrakis(hydroxymethyl)-14-methyl-17-(2-(methylthio)ethyl)-4,7,10,13,16,19,22,25,28-nonaoxo-3,6,9,12,15,18,21,24-octaazaoctacosanamido)-43-(3-amino-3-oxopropyl)-40-(4-aminobutyl)-49-benzyl-28,37-di((S)-sec-butyl)-34-(carboxymethyl)-13,31-bis(3-guanidinopropyl)-16-(hydroxymethyl)-10-isobutyl-19-isopropyl-22-methyl-6,9,12,15,18,21,24,27,30,33,36,39,42,45,48,51-hexadecaoxo-1,2-dithia-5,8,11,14,17,20,23,26,29,32,35,38,41,44,47,50-hexadecaazacyclotripentacontane-4-carboxamido)-2-benzyl-8-(3-guanidinopropyl)-5,11-diisobutyl-4,7,10,13,16-pentaoxo-3,6,9,12,15-pentaazanonadecanedioic acid
IUPAC Name(2S,5S,8S,11S,17S)-17-((4R,10S,13S,16S,19S,22S,28S,31S,34S,37S,40S,43S,49S,52R)-52-((2S,5S,8S,11S,14S,17S,20S,23S,26S)-11-((1H-imidazol-4-yl)methyl)-26,28-diamino-20-(4-aminobutyl)-2,5,8,23-tetrakis(hydroxymethyl)-14-methyl-17-(2-(methylthio)ethyl)-4,7,10,13,16,19,22,25,28-nonaoxo-3,6,9,12,15,18,21,24-octaazaoctacosanamido)-43-(3-amino-3-oxopropyl)-40-(4-aminobutyl)-49-benzyl-28,37-di((S)-sec-butyl)-34-(carboxymethyl)-13,31-bis(3-guanidinopropyl)-16-(hydroxymethyl)-10-isobutyl-19-isopropyl-22-methyl-6,9,12,15,18,21,24,27,30,33,36,39,42,45,48,51-hexadecaoxo-1,2-dithia-5,8,11,14,17,20,23,26,29,32,35,38,41,44,47,50-hexadecaazacyclotripentacontane-4-carboxamido)-2-benzyl-8-(3-guanidinopropyl)-5,11-diisobutyl-4,7,10,13,16-pentaoxo-3,6,9,12,15-pentaazanonadecanedioic acid
MDL No.MFCD00133150
Molecular FormulaC146H239N47O44S3
Molecular Weight3453.00
SMILESCC[C@H](C)[C@@H]1NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(N)=O)NC(=O)CNC(=O)[C@H](CC2=CC=CC=C2)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H](CC2=CNC=N2)NC(=O)[C@H](C)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC(N)=O)CSSC[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC2=CC=CC=C2)C(=O)O)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CO)NC(=O)[C@H](C(C)C)NC(=O)[C@H](C)NC(=O)CNC1=O
InChI KeyCKSKSHHAEYGHSB-LBCJMRPYSA-N
SynonymBNP-32 | BNP (1-32), rat | Brain Natriuretic Peptide-32 rat | Brain Natriuretic Peptide-32 rat, >=97% (HPLC), powder | DTXSID50745570 | 14-45-Brain natriureticpeptide-45(rat)(9ci) | PUBCHEM_71308564 | J-006379
CAS No.133448-20-1
PubChem CID71308564

Synthetic Route by SureRoute

1. ACFXCD755 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACFXCD755 route product structure diagram
    ACFXCD755133448-20-1
Inquiry

2. ACFXCD755 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACFXCD755 route product structure diagram
    ACFXCD755133448-20-1
Inquiry

Comments (0)